SSTR3 Agonist-1 (Compound EX 38) is an orally active SSTR3 agonist, with an EC 50 of 0.14 nM. SSTR3 Agonist-1 reduces the kidney cystic index. SSTR3 Agonist-1 can be used in the research of autosomal dominant polycystic kidney disease [1].
References:
[1]. Sun Hee Kim, et al. Somatostatin subtype receptor 3 (sstr3) agonists and uses thereof. WO2025111318A1. WIPO (PCT). 2024-11-20.
References:
[1]. Sun Hee Kim, et al. Somatostatin subtype receptor 3 (sstr3) agonists and uses thereof. WO2025111318A1. WIPO (PCT). 2024-11-20.
















